Diabetes mellitus is known for its hyperglycemia symptoms resulting from glucose intolerance caused by impaired insulin secretion and/or elevated insulin resistance. Accurate treatment for patients with diabetes mellitus is extremely important for preventing both acute and chronic diabetic complications. While type 2 and type 1 diabetes mellitus are most common, there is increasing recognition that treatment-refractory diabetes cases could have other endocrinological or metabolic disorders. These complications include Cushing’s disease, pheochromocytoma/paraganglioma, primary aldosteronism, acromegaly, adult growth hormone deficiency, hyperthyroidism, and hypothyroidism.
The treatment for endocrinological or metabolic diseases may drastically improve glucose intolerance. Meanwhile, the medication for endocrinological or metabolic diseases could be associated with glucose intolerance. Besides, the detailed mechanisms of glucose intolerance in patients with endocrinological or metabolic diseases have been revealed. Hence, updated clinical knowledge is needed to underline the mechanisms.
This Research Topic aims to present recent advances and current perspectives on diabetes mellitus and glucose intolerance associated with endocrinological or metabolic diseases. We welcome reviews, mini-reviews, original research, methods, case reports, and perspective articles.
We look forward to receiving and compiling a concise source of updated knowledge in this critical area of research that holds great promise for improved patient care.
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Diabetes mellitus is known for its hyperglycemia symptoms resulting from glucose intolerance caused by impaired insulin secretion and/or elevated insulin resistance. Accurate treatment for patients with diabetes mellitus is extremely important for preventing both acute and chronic diabetic complications. While type 2 and type 1 diabetes mellitus are most common, there is increasing recognition that treatment-refractory diabetes cases could have other endocrinological or metabolic disorders. These complications include Cushing’s disease, pheochromocytoma/paraganglioma, primary aldosteronism, acromegaly, adult growth hormone deficiency, hyperthyroidism, and hypothyroidism.
The treatment for endocrinological or metabolic diseases may drastically improve glucose intolerance. Meanwhile, the medication for endocrinological or metabolic diseases could be associated with glucose intolerance. Besides, the detailed mechanisms of glucose intolerance in patients with endocrinological or metabolic diseases have been revealed. Hence, updated clinical knowledge is needed to underline the mechanisms.
This Research Topic aims to present recent advances and current perspectives on diabetes mellitus and glucose intolerance associated with endocrinological or metabolic diseases. We welcome reviews, mini-reviews, original research, methods, case reports, and perspective articles.
We look forward to receiving and compiling a concise source of updated knowledge in this critical area of research that holds great promise for improved patient care.
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.